Thomas Pincez: Clonal Hematopoiesis Linked to Increased Risk of Autoimmune Hemolytic Anemia
Thomas Pincez, Adjunct Professor at McGill University, Assistant Professor at University of Montreal, Clinician-Scientist at Azrieli Research Centre of CHU Sainte-Justine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Advances, adding:
“Clonal hematopoiesis increases the risk of immune thrombocytopenia.
But what about autoimmune hemolytic anemia, another type of immune cytopenia?
Here we showed that autoimmune hemolytic anemia risk is increased by clonal hematopoiesis with the same order of magnitude as immune thrombocytopenia.
However, some clones, such as JAK2 conferring a high risk of immune thrombocytopenia, were not found in patients with autoimmune hemolytic anemia, suggesting the existence of immune cytopenia-specific risks.
Even larger cohorts will be needed to assess this point!
Congrats Stennio Faria for this work!”
Title: Clonal Hematopoiesis in Autoimmune Hemolytic Anemia
Authors: Stennio Da Silva Faria, Rafaël Moisan, Estelle Lecluze, Thomas Pincez
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 9, 2026, 14:30Alejandro González Veliz: 2026 ESC Guidelines Expand Cardiac Rehabilitation Beyond Post-Event Recovery
-
Sep 9, 2026, 13:59Natalie Arnold: Biomarkers and the Hidden Burden of CHD
-
Sep 9, 2026, 13:11Ron DePinho: A Negative Trial Does Not Repudiate Inflammation as a Cardiovascular Target
-
Sep 9, 2026, 13:10Ahmad Gharehbaghian: Visiting the Alborz Provincial Blood Transfusion Center
-
Sep 9, 2026, 13:09Oraianthi Fiste: New Collection on Cancer-Associated Thrombosis From Mechanisms to Precision Medicine
-
Sep 9, 2026, 13:07Can Özlü: Can the HALP Score Help Identify Thrombotic Risk in Myeloproliferative Neoplasms?
-
Sep 9, 2026, 13:06Ohanna Cavalcanti Bezerra: Why Does DVT Lead to PE in Some Patients but Not Others?
-
Sep 9, 2026, 13:04Usman Shehzad: Transforming Patient Lives with INR Self-Testing
-
Sep 9, 2026, 13:02Edward Lee Carter: Provoked VTE May Not Tell the Whole Story About Recurrence Risk